在怀孕期间接受推接种疫苗:意大利南部的一项横截面研究
Francesca Licata1, Marika Romeo1, Concetta Riillo1
1Department of Health Sciences, School of Medicine, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Frontiers in public health
|May 30, 2023
概括
意大利的流感和Tdap疫苗的孕产妇免疫率较低,这是由于孕妇对疫苗的认识和犹不决. 教育对于改善疫苗接种和保护母亲和新生儿免受疫苗可预防的疾病至关重要.
科学领域:
- 公共卫生 公共卫生
- 免疫学 免疫学 免疫学
- 孕产妇健康 孕产妇健康
背景情况:
- 建议孕妇接种疫苗,以预防疫苗可预防的疾病 (VPDs).
- 意大利的流感疫苗和结节炎-白血病-细胞性百日咳 (Tdap) 疫苗的孕产妇免疫率显著较低.
- 有限的知识和特定因素影响怀孕期间的疫苗接种决策.
研究的目的:
- 评估意大利孕妇在VPD和怀孕期间免疫接种方面的知识.
- 确定影响他们关于怀孕期间接种疫苗的决定的因素.
- 探索人们对疫苗安全性的看法以及与怀孕期间的VPD相关的风险.
主要方法:
- 从2021年10月到2022年4月,在意大利南部进行了一项横截面研究.
- 招募了18岁以上的孕妇,能够理解意大利语.
- 一个32项调查问卷评估了关于母婴免疫接种的知识,态度和疫苗接种情况.
主要成果:
- 只有61%的人知道推接种流感疫苗,48.7%的人承认怀孕时存在流感风险.
- 很大一部分 (74.1%) 错误地认为MMR疫苗在怀孕期间是建议的.
- 尽管人们普遍相信疫苗安全性,但女性认为对未出生的孩子有风险 (中位数6/10),并担心感染 pertussis (中位数6/10) 和流感 (中位数5/10).
- 疫苗接种率很低:流感为21.1%,Tdap为36.5%.
结论:
- 意大利孕妇的低疫苗接种率与关于VPD和疫苗安全性的误解有关.
- 负面的态度和不切实际的风险感知阻碍了疫苗接种.
- 有针对性的教育对于赋予孕妇权力,使他们能够做出明智的疫苗接种选择至关重要,从而增加免疫覆盖率.
关键词:
这是COVID-19疫苗.Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap Tdap流感 流感 流感 流感 流感怀孕 怀孕 怀孕 怀孕 怀孕孕妇 孕妇 孕妇 孕妇接种疫苗 接种疫苗疫苗可以预防的疾病 (VPDs)
相关概念视频
01:51Vaccinations
44.9K
Overview
44.9K
01:22Development of Immunocompetence
369
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
369
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
01:15Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K